Pharma CMOs M&A to continue despite challenging borrowing environment: GlobalData

CMOs showed an increasing reluctance to take on debt in 2022. Even still, large CMOs made acquisitions of companies and facilities to enhance their capabilities or scale of production. Private equity investment in CMOs over the previous five years peaked in 2022.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/YU5QzLX
via